Cargando…

Characterization of Sitagliptin Use in Patients with Type 2 Diabetes and Chronic Kidney Disease by Cross-Sectional Analysis of a Medical Insurance Claims Database

INTRODUCTION: Chronic kidney disease (CKD) is common in patients with type 2 diabetes (T2DM) and makes them particularly susceptible to safety/tolerability issues related to many classes of oral antihyperglycemic agents (OAHA). Dipeptidyl peptidase-4 inhibitors (DPP-4is) like sitagliptin are general...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brodovicz, Kimberly G., Chen, Yong, Liu, Zhiwen, Ritchey, Mary E., Liao, Jane, Engel, Samuel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2015
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674473/ https://www.ncbi.nlm.nih.gov/pubmed/26438107 http://dx.doi.org/10.1007/s13300-015-0133-z

Ejemplares similares

Characteristics of Elderly Patients Initiating Sitagliptin or Non-DPP-4-Inhibitor Oral Antihyperglycemic Agents: Analysis of a Cross-Sectional US Claims Database
por: Wang, Tongtong, et al.
Publicado: (2018)

Brief Report: Impact of COVID-19 in Individuals with Autism Spectrum Disorders: Analysis of a National Private Claims Insurance Database
por: Karpur, Arun, et al.
Publicado: (2021)

Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency
por: Raji, Annaswamy, et al.
Publicado: (2020)

Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis
por: Charbonnel, Bernard, et al.
Publicado: (2017)

Patient-Level Exposure to Actionable Pharmacogenomic Medications in a Nationally Representative Insurance Claims Database
por: Bianchini, Monica L., et al.
Publicado: (2023)

Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study
por: Francis-Sedlak, Megan, et al.
Publicado: (2020)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

Association Between Statins and the Risk of Kidney Cancer Incidence and Mortality Using the Korean National Health Insurance Claims Database
por: Kim, Dong-Sook, et al.
Publicado: (2022)

Positive Predictive Value of ICD-10 Codes for Cerebral Venous Sinus Thrombosis in Taiwan’s National Health Insurance Claims Database
por: Liao, Shu-Chen, et al.
Publicado: (2022)

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin
por: Steinberg, Helmut, et al.
Publicado: (2013)

Hospital Claims and the Insurance Surplus
Publicado: (1921)

Sitagliptin Results in a Decrease of Truncated Apolipoprotein C1
por: Skinner, Nicole E. B., et al.
Publicado: (2015)

The Economic Burden of Stroke Based on South Korea’s National Health Insurance Claims Database
por: Cha, Yu-Jin
Publicado: (2018)

Development of algorithms for identifying patients with Crohn’s disease in the Japanese health insurance claims database
por: Morikubo, Hiromu, et al.
Publicado: (2021)

Incidence of Mumps Deafness in Japan, 2005–2017: Analysis of Japanese Insurance Claims Database
por: Takagi, Akira, et al.
Publicado: (2022)

Data resource profile: JMDC claims database sourced from health insurance societies
por: Nagai, Katsuhiko, et al.
Publicado: (2021)

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
por: Inzucchi, S. E., et al.
Publicado: (2015)

Prevalence, treatments and medical cost of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Ogino, Mieko, et al.
Publicado: (2017)

Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims
por: Desai, Rishi J., et al.
Publicado: (2019)

Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database
por: Mori, Takahiro, et al.
Publicado: (2022)

The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claims database
por: Chang, Chia-Hsien, et al.
Publicado: (2018)

Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database
por: Sakamoto, Masako, et al.
Publicado: (2017)

Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002
por: Brinks, Ralph, et al.
Publicado: (2016)

Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
por: Anderson-Smits, Colin, et al.
Publicado: (2023)

Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage
por: Kimura, Shinya, et al.
Publicado: (2010)

Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database
por: Bouée, Stéphane, et al.
Publicado: (2016)

Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database
por: Broder, Michael S., et al.
Publicado: (2018)

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis
por: REINHARDT, Maximilian, et al.
Publicado: (2021)

Association study between drug prescriptions and Alzheimer’s disease claims in a commercial insurance database
por: Hu, Eric, et al.
Publicado: (2023)

The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases
por: Ramcharran, Darmendra, et al.
Publicado: (2023)

Unemployment insurance claims and COVID-19
por: Sjoquist, David, et al.
Publicado: (2021)

Health claims databases used for kidney research around the world
por: van Oosten, Manon J M, et al.
Publicado: (2020)

Linkage Rate Between Data From Health Checks and Health Insurance Claims in the Japan National Database
Publicado: (2014)

Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in Japan
por: Tokunaga, Kengo, et al.
Publicado: (2021)

Use of the dental formula from the National Database of Health Insurance Claims and Specific Health Checkups of Japan
por: Tsuneishi, Midori, et al.
Publicado: (2022)

Nationwide comprehensive epidemiological study of rare diseases in Japan using a health insurance claims database
por: Ninomiya, Kota, et al.
Publicado: (2022)

How are new drugs disseminated in Japan? Analysis using the National Database of Health Insurance Claims of Japan
por: Watanabe, Tomone, et al.
Publicado: (2022)

Understanding and Utilizing Claim Data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) Database for Research
por: Kyoung, Dae-Sung, et al.
Publicado: (2022)

Pancreatic Safety of Sitagliptin in the TECOS Study
por: Buse, John B., et al.
Publicado: (2017)

Recent transition of medical cost and relapse rate of multiple sclerosis in Japan based on analysis of a health insurance claims database
por: Kawachi, Izumi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_133n74tnpvjia4v6apl1btuefj